HK1029622A1 - A method of diagnosis - Google Patents

A method of diagnosis

Info

Publication number
HK1029622A1
HK1029622A1 HK01100344.2A HK01100344A HK1029622A1 HK 1029622 A1 HK1029622 A1 HK 1029622A1 HK 01100344 A HK01100344 A HK 01100344A HK 1029622 A1 HK1029622 A1 HK 1029622A1
Authority
HK
Hong Kong
Prior art keywords
predicting
development
lung damage
damage
diagnosing
Prior art date
Application number
HK01100344.2A
Other languages
English (en)
Inventor
Ian Ross Doyle
Andrew David Bersten
Terence Evan Nicholas
Original Assignee
Southern Medical Diagnostics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO8999A external-priority patent/AUPO899997A0/en
Priority claimed from AUPP5062A external-priority patent/AUPP506298A0/en
Application filed by Southern Medical Diagnostics Pty Ltd filed Critical Southern Medical Diagnostics Pty Ltd
Publication of HK1029622A1 publication Critical patent/HK1029622A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Control Of Eletrric Generators (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Vehicle Body Suspensions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK01100344.2A 1997-09-05 2001-01-12 A method of diagnosis HK1029622A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO8999A AUPO899997A0 (en) 1997-09-05 1997-09-05 A method of diagnosis
AUPP5062A AUPP506298A0 (en) 1998-08-04 1998-08-04 A method of diagnosis - II
PCT/AU1998/000723 WO1999013337A1 (en) 1997-09-05 1998-09-04 A method of diagnosis

Publications (1)

Publication Number Publication Date
HK1029622A1 true HK1029622A1 (en) 2001-04-06

Family

ID=25645598

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01100344.2A HK1029622A1 (en) 1997-09-05 2001-01-12 A method of diagnosis

Country Status (11)

Country Link
US (1) US8097420B1 (xx)
EP (1) EP1018018B1 (xx)
JP (2) JP4584445B2 (xx)
AT (1) ATE476662T1 (xx)
CA (1) CA2303169C (xx)
DE (1) DE69841804D1 (xx)
DK (1) DK1018018T3 (xx)
HK (1) HK1029622A1 (xx)
IL (3) IL134880A0 (xx)
NZ (1) NZ503175A (xx)
WO (1) WO1999013337A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100348922B1 (ko) 1996-02-28 2002-11-18 마쯔시다덴기산교 가부시키가이샤 고해상도및입체영상기록용광디스크,광디스크재생장치및광디스크기록장치
WO2004077056A1 (en) * 2003-02-27 2004-09-10 Lung Health Diagnostics Pty. Ltd. A method of diagnosis and agents useful for same
SE0203591D0 (sv) * 2002-12-04 2002-12-04 Siemens Elema Ab Förfarande för beredning av ett mediakament och en medicinsk anordning
EP1522857A1 (en) * 2003-10-09 2005-04-13 Universiteit Maastricht Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
US7659087B2 (en) * 2004-07-23 2010-02-09 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
EP1845379A1 (en) * 2006-04-13 2007-10-17 F. Hoffmann-La Roche AG Means and methods for the differentiation of cardiac and pulmonary causes of shortness of breath
EP1882945A1 (en) 2006-07-28 2008-01-30 F.Hoffmann-La Roche Ag Means and methods for the differentiation of cardiac and pulmonary causes of acute shortness of breath
EP2031397A1 (en) 2007-08-30 2009-03-04 F. Hoffmann-La Roche AG Surfactant proteins B and D in differentiating the causes of shortness of breath
WO2009098627A1 (en) 2008-02-07 2009-08-13 Koninklijke Philips Electronics N.V. Apparatus for measuring and predicting patients' respiratory stability
WO2012130731A1 (en) 2011-03-25 2012-10-04 Roche Diagnostics Gmbh MEASUREMENT OF C-TERMINAL proSP-B
CN102552879B (zh) * 2012-03-15 2013-11-06 北京双鹤现代医药技术有限责任公司 肺表面活性提取物与肺表面活性物质相关蛋白a的组合物、制备方法及其制药用途
EP2650684A1 (en) 2012-04-10 2013-10-16 Roche Diagniostics GmbH Pro SP-B and NT-proBNP based diagnosis in patients with pneumonia
EP2615459A1 (en) 2012-04-27 2013-07-17 Roche Diagniostics GmbH proSP-B based diagnosis of distal airway involvement in asthma
EP2866033A1 (en) 2013-10-23 2015-04-29 Roche Diagniostics GmbH Differential diagnosis of acute dyspnea based on C-terminal proSP-B, KL-6 and BNP-type peptides
GB201511207D0 (en) * 2015-06-25 2015-08-12 Xvivo Perfusion Ab Isolated organ evaluation and treatment
EP3287921B1 (en) * 2016-08-26 2020-11-04 Nxp B.V. Spoken pass-phrase suitability determination

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0224590B1 (en) 1985-05-31 1994-11-23 Teijin Limited Method for assaying human pulmonary surface active substance and reagent kit therefor
DE3888823T2 (de) 1987-09-01 1994-08-11 Teijin Ltd Verfahren zum testen einer wirksamen substanz die sich auf der oberfläche menschlicher lungen befindet.
JP2517696B2 (ja) * 1990-04-27 1996-07-24 帝人株式会社 肺疾患マ―カ―蛋白の測定法
AP257A (en) * 1991-04-26 1993-06-03 Surface Active Ltd A method of releasing an antigen from an antibody and methods for their use in diagnosis and therapy.
CA2115171C (en) * 1992-06-09 1998-05-05 Takeshi Inoue Monoclonal antibodies to human pulmonary surfactant apoprotein d and use thereof
US5670328A (en) 1992-06-09 1997-09-23 Yamasa Corporation Monoclonal antibodies to human pulmonary surfactant apoprotein D and use thereof
AU4908799A (en) 1998-07-24 2000-02-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Determination of the hydrophobic pulmonary surfactant protein sp-c
US7713705B2 (en) 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof

Also Published As

Publication number Publication date
JP2001516057A (ja) 2001-09-25
US8097420B1 (en) 2012-01-17
IL134880A0 (en) 2001-05-20
DE69841804D1 (de) 2010-09-16
EP1018018A4 (en) 2004-12-22
CA2303169C (en) 2009-11-10
IL134880A (en) 2006-12-10
JP4584445B2 (ja) 2010-11-24
NZ503175A (en) 2002-11-26
CA2303169A1 (en) 1999-03-18
DK1018018T3 (da) 2010-11-15
WO1999013337A1 (en) 1999-03-18
ATE476662T1 (de) 2010-08-15
JP2010197405A (ja) 2010-09-09
EP1018018A1 (en) 2000-07-12
IL172185A0 (en) 2009-02-11
EP1018018B1 (en) 2010-08-04

Similar Documents

Publication Publication Date Title
IL172185A0 (en) Method of diagnosis lung damage
DK1328421T3 (da) Fremgangsmåde og apparat til vurdering og forbedring af en førers arbejdspræstation
DE69423436T2 (de) An lipoprotein gebundene phospholipase a2, inhibitoren davon und deren verwendung für diagnose und therapie
GB0203446D0 (en) Detection and/or monitoring of synuclein-related diseases
FR2847267B1 (fr) Procede de test de l'activite d'une substance potentiellement active pour inhiber l'activite enzymatique de la phospholipase a2
EP1099102A4 (en) TRACE DETECTION OF ANALYTES BY ARTIFICIAL OLFAKTOMETRY
DE69821931D1 (de) System zum genauen überwachen des kardiovaskulären zustandes eines lebewesens
ES2183881T3 (es) Microesferas rellenas con gas con cubiertas que contienen fluor.
ZA964819B (en) Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds.
FI941512A0 (fi) Laitteisto ja menetelmä työstökoneen toiminnallisen tehokkuuden määrittämiseksi
CY1109062T1 (el) Μεθοδοι ανιχνευσεως και αναστολης της αγγειογενεσεως
SE0101912D0 (sv) a method and an apparatus for measuring functional, residual capacity (FRC) and cardiac output (CO)
DE69404460D1 (de) Zell-test für alzheimersche krankheit
ES2148967T3 (es) Sustancias y metodos destinados al diagnostico y al tratamiento de la pre-eclampsia.
ZA964818B (en) Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds.
FR2842512B1 (fr) Systeme de securisation du fonctionnement des portes palieres d'un ascenseur
BR0207548A (pt) Método de controle de poeira automatizado
DE69505782D1 (de) System zum Schätzen des Zustandes eines Fahrzeuges
IL127033A0 (en) A method for early detection of lysosomal storage disorders and a kit for detecting the same
WO1998041238A3 (en) Methods and kits for treating and diagnosing leiomyomas
CA2091637A1 (en) Call Progress Monitoring
DE69606609D1 (de) Wandleranordnung für akustische Abbildung
ATE200792T1 (de) Reinigungsmittel für anlagen der lebensmittelindustrie, seine verwendung und verfahren zum reinigen dieser anlagen
IL135957A0 (en) Diagnostics and therapeutics for chronic obstructive airway disease
AUPM666894A0 (en) Diagnostic methods and compositions

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140904